AB DERMATOPATHOLOGY CONSULTATIONS LIMITED
🌿Early-stageactive
SC802186 · ltd · incorporated 2024-03-08
Investment thesis
Growth-phase business — story-led; valuation sensitive to momentum.
Why interesting: Trading is scaling; acquirers paying for trajectory get disproportionate leverage.
Why risky: Price often leads fundamentals; dependency on founder often high.
🔒Estimated value
—
Upgrade to see
Turnover
—
year to Mar 2025
Net worth
£60.2k
book net assets
Opportunity
76/100
Strong
What this business does
Primary activity: Specialist medical practice activities
Sector: Human health & social work
Investor take
PursueAsset-holding vehicle. Family succession underway — not a classic acquisition target.
Opportunity 76/100 (strong), bankability 70/100. Same-surname younger director in place — likely family handover, not open to sale. Share purchase looks the cleaner deal structure. Most likely exit: strategic trade sale (73/100).
Data confidence
Overall: medium (69/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Company profile
address, 1 SIC codes, incorporation date
100
Financials
1 year of iXBRL accounts extracted (no YoY comparison) + narrative notes parsed
50
Lenders & charges
Confirmed no charges registered
85
Directors & officers
3 officers (3 active, 3 linked, 3 with DOB)
90
Ownership & PSC
1 active PSC(s) of 1 total, 1 with control declared
90
Director network
Network not yet resolved
30
Filing history
9 filings
60
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
76/100Strong
PassWatchWorth a lookStrongExceptional
Solid opportunity signal. Worth a dedicated memo and management meeting.
Business quality
60
Adequate — check latest filings for context.
Acquirability
75
Strong succession / seller-readiness signals.
Risk profile
85
Few red flags.
Signal strength
90
Good data coverage for analysis.
Signals from accounts
Derived from iXBRL accounts · FRS 102Positive net assets
Net assets £60,168
Key financials
1 year extracted from filed iXBRL accountsCash
£73k
Net Worth
£60k
Current Assets
£82k
Current Liabilities
—
Financials
Extracted from Companies House accounts · FRS 102| Metric | 2025-03-31 |
|---|---|
| Total assets | £60.2k |
| Current assets | £82.1k |
| Cash | £73.1k |
| Debtors | £9.0k |
| Net assets | £60.2k |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
🔒Filing-note intelligence
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
Last 30 days
2
filings
- • 2 officers
Last 90 days
3
filings
- • 2 officers
- • 1 confirmation-statement
Last 180 days
4
filings
- • 2 officers
- • 1 confirmation-statement
- • 1 accounts
Counts from Companies House filing history.
Corporate timeline (11 events)Click to expand
- 2026-04-01📄appoint-person-director-company-with-name-dateofficers · AP01
- 2026-04-01📄appoint-person-director-company-with-name-dateofficers · AP01
- 2026-03-31➕BISWAS, Raina appointeddirector
- 2026-03-31➕BOHRA, Sangita, Dr appointeddirector
- 2025-10-30📄accounts-with-accounts-type-unaudited-abridgedaccounts · AA
- 2025-06-09📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2025-05-31📄gazette-filings-brought-up-to-dategazette · DISS40
- 2025-05-27📄gazette-notice-compulsorygazette · GAZ1
- 2024-03-08🏢Company incorporatedAs AB DERMATOPATHOLOGY CONSULTATIONS LIMITED
- 2024-03-08➕BISWAS, Asok appointeddirector
- 2024-03-08📄incorporation-companyincorporation · NEWINC
Owner dependency
71/100
High — earn-out structure requiredMaterial founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.
FACTORS
- +Senior director age: Director aged approximately 58 — approaching natural succession window.
- +Family involvement: Multiple officers share a surname — likely family business, which concentrates governance.
- +Young company: Only 2.1 years old — management layer unlikely to be developed.
Red flags
cleanNo red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)
Shareholders & ownership
1 active beneficial owner| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Mr Asok Biswas Individual · British · DOB 10/1968 · age 58 | 50–75% | 50–75% | board control50-75% shares · 50-75% voting · board control | 08/03/2024 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · EH postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| A.E.N. LIMITED→ SC256550 · est 2003 · no financials extracted | — | — | — | — | 22y | — | — |
| AADENT 1 LIMITED→ SC868082 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| ABC HEARING LTD→ SC363286 · est 2009 · no financials extracted | — | — | — | — | 16y | — | — |
| ACUPUNCTURE & HEALTH CENTRE LTD→ SC383161 · est 2010 · no financials extracted | — | — | — | — | 15y | — | — |
| AD MEDICAL LIMITED→ SC630065 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| ADAM SMITH PODIATRY LTD→ SC806446 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
| ADAMANTIUM COACHING LTD→ SC757179 · est 2023 · no financials extracted | — | — | — | — | 3y | — | — |
| ADFAK GUVYSHOW SPORT AND ACADEMY LIMITED→ SC644867 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| ADHDDEGREE LTD→ SC822923 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| AGASACK LIMITED→ SC586663 · est 2018 · no financials extracted | — | — | — | — | 8y | — | — |
| AGE ETERNAL LIMITED→ SC767087 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| AGE SCOTLAND→ SC153343 · est 1994 · no financials extracted | — | — | — | — | 31y | — | — |
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions
7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →🔒Advanced scoring suite
Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Statusactive
Typeltd
Incorporated2024-03-08
Jurisdictionscotland
Primary SIC86220 — Specialist medical practice activities
Registered office
15 Manor Place
Edinburgh
EH3 7DH
United Kingdom
Filing status
Accounts
Next due: 2026-12-31
Last made up to: 2025-03-31
Confirmation statement
Next due: 2027-03-21
Last: 2026-03-07
Officers (3 active · 0 resigned)
BISWAS, Asok→
Activedirector · ~58y · appointed 2024-03-08
View their other companies + combined net worth →
BISWAS, Raina→
Activedirector · ~24y · appointed 2026-03-31
View their other companies + combined net worth →
BOHRA, Sangita, Dr→
Activedirector · ~57y · appointed 2026-03-31
View their other companies + combined net worth →
Click a director name to see their full track record across all companies.
Recent filings (9 total)
appoint-person-director-company-with-name-date
officers · AP01
2026-04-01
appoint-person-director-company-with-name-date
officers · AP01
2026-04-01
confirmation-statement-with-no-updates
confirmation-statement · CS01
2026-03-18
accounts-with-accounts-type-unaudited-abridged
accounts · AA
2025-10-30
change-registered-office-address-company-with-date-old-address-new-address
address · AD01
2025-06-09
confirmation-statement-with-no-updates
confirmation-statement · CS01
2025-06-02
gazette-filings-brought-up-to-date
gazette · DISS40
2025-05-31
gazette-notice-compulsory
gazette · GAZ1
2025-05-27
incorporation-company
incorporation · NEWINC
2024-03-08